SCHEMBL6510159

SCHEMBL6510159

CN(C)Cc1ccc2oc(C(=O)NO)cc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 5/20 0.52
LMNA P02545 2/20 0.47
TP53 P04637 1/20 0.47
TAS1R3 Q7RTX0 4/20 0.44
TAS1R1 Q7RTX1 4/20 0.44
HDAC3 O15379 3/20 0.43
HDAC4 P56524 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43
HDAC5 Q9UQL6 2/20 0.43
OPRM1 P35372 2/20 0.43
TMEM97 Q5BJF2 2/20 0.43
SIGMAR1 Q99720 2/20 0.43
ACKR3 P25106 1/20 0.43
OPRK1 P41145 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11493953 0.83 LMNA (0.66) LMNATP53ALDH1A1HPGDKDM4E
Hydrochloric Acid SCHEMBL8689213 0.82 LMNA (0.42) HDAC6LMNATP53TAS1R3TAS1R1
SCHEMBL6512208 0.79 MAOA (0.49) LMNATP53TAS1R3TAS1R1RAB9A
SCHEMBL10963543 0.77 CA12 (0.54) LMNATP53ALDH1A1HPGDKDM4E
SCHEMBL10968103 0.77 CA12 (0.41) HDAC6LMNATP53
SCHEMBL6506293 0.75 HDAC1 (0.58) HDAC6TP53HDAC4HDAC1HDAC8
SCHEMBL6506238 0.74 LMNA (0.46) HDAC6LMNATP53HDAC3HDAC1
SCHEMBL6512859 0.74 RAB9A (0.41) TAS1R3TAS1R1HDAC3HDAC1HDAC2
SCHEMBL10507430 0.73 CA2 (0.56) LMNATP53
SCHEMBL26323649 0.73 CA12 (0.56) LMNATP53TAS1R3TAS1R1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO claimed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US claimed
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO disclosed
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO disclosed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137234-A1 Histone deacetylase inhibitors HDAC1, HDAC5, HDAC11 HDAC6 10/4885LMNA 680/4885TP53 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.